In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole
- 29 July 2007
- Vol. 50 (6) , 447-450
- https://doi.org/10.1111/j.1439-0507.2007.01409.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- In Vitro Activities of Three Licensed Antifungal Agents against Spanish Clinical Isolates of Aspergillus sppAntimicrobial Agents and Chemotherapy, 2003
- Studies of In Vitro Activities of Voriconazole and Itraconazole against Aspergillus Hyphae Using Viability StainingAntimicrobial Agents and Chemotherapy, 2001
- Antifungal Drug Resistance in AspergillusJournal of Infection, 2000
- A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592)Journal of Antimicrobial Chemotherapy, 2000
- In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazoleJournal of Antimicrobial Chemotherapy, 1999
- In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungiJournal of Antimicrobial Chemotherapy, 1998
- In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.Journal of Antimicrobial Chemotherapy, 1998
- In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin BJournal of Antimicrobial Chemotherapy, 1998
- In-vitro isolation and antifungal susceptibility of amphotericin B-resistant mutants of Aspergillus fumigatus.Journal of Antimicrobial Chemotherapy, 1998
- Resistance of Aspergillus fumigatus to ItraconazoleScandinavian Journal of Infectious Diseases, 1998